R
Raymond K. Y. Tsang
Researcher at University of Hong Kong
Publications - 106
Citations - 1860
Raymond K. Y. Tsang is an academic researcher from University of Hong Kong. The author has contributed to research in topics: Nasopharyngeal carcinoma & Transoral robotic surgery. The author has an hindex of 24, co-authored 94 publications receiving 1544 citations. Previous affiliations of Raymond K. Y. Tsang include The Chinese University of Hong Kong & Queen Mary Hospital.
Papers
More filters
Journal ArticleDOI
Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma.
Angela Bik Yu Hui,Yvonne Y. Y. Or,Hirokuni Takano,Raymond K. Y. Tsang,Ka Fai To,Xin Yuen Guan,Jonathan S.T. Sham,Katherine Wing Ki Hung,Cleo N.Y. Lam,Charles Andrew van Hasselt,Wen Lin Kuo,Joe W. Gray,Dolly P. Huang,Kwok Wai Lo +13 more
TL;DR: The findings suggest that cyclin D1 is a target oncogene at 11q13 in nasopharyngeal carcinoma and its activation plays a significant role in nasolympic carcinoma tumorigenesis.
Journal ArticleDOI
Transoral robotic surgery of the parapharyngeal space: a case series and systematic review.
TL;DR: The purpose of this study was to evaluate the current use of transoral robotic surgery (TORS) in the treatment of parapharyngeal space (PPS) neoplasms through a case series and systematic analysis.
Journal Article
Quantitative Epstein-Barr Virus DNA Analysis and Detection of Gene Promoter Hypermethylation in Nasopharyngeal (NP) Brushing Samples from Patients with NP Carcinoma
Joanna H.M. Tong,Raymond K. Y. Tsang,Kwok Wai Lo,John K. S. Woo,Joseph Kwong,Michael W.Y. Chan,Alex R. Chang,Charles Andrew van Hasselt,Dolly P. Huang,Ka Fai To +9 more
TL;DR: The study demonstrated the feasibility of detecting multiple molecular tumor markers in NP brushing samples with a high sensitivity and specificity for NPC detection and offers a powerful yet noninvasive approach for the diagnosis of NPC in high-risk populations.
Journal ArticleDOI
Olfactory Dysfunction in Coronavirus Disease 2019 Patients: Observational Cohort Study and Systematic Review
Tom Wai-Hin Chung,Siddharth Sridhar,Siddharth Sridhar,Anna Jinxia Zhang,Kwok-Hung Chan,Hang Long Li,Fergus Kai Chuen Wong,Ming-Yen Ng,Raymond K. Y. Tsang,Andrew Chak-Yiu Lee,Zhimeng Fan,Ronnie S.L. Ho,Shiobhon Y Luk,Wai Kuen Kan,Sonia Hiu Yin Lam,Alan Ka Lun Wu,Sau Man Leung,Wai-Ming Chan,Pauline Yeung Ng,Pauline Yeung Ng,Kelvin K. W. To,Kelvin K. W. To,Vincent C.C. Cheng,Kwok Cheung Lung,Ivan Hung,Ivan Hung,Kwok-Yung Yuen +26 more
TL;DR: Olfactory dysfunction is common in COVID-19 and may be the only symptom and the prevalence of olfactory disturbances in CO VID-19 ranged from 5% to 98%.
Journal ArticleDOI
Review of Salivary Gland Neoplasms
TL;DR: Some of the more important aspects in the management of salivary gland tumours are highlighted, including the role of chemotherapy remains largely palliative.